High Prevalence of Potential Drug-Drug Interactions Among Patients Treated with Off-label Therapies for COVID-19

High Prevalence of Potential Drug-Drug Interactions Among Patients Treated with Off-label Therapies for COVID-19

Background: During the first wave of the COVID-19 pandemic, severe patients were treated with the off-label drugs hydroxychloroquine and lopinavir/ritonavir. The aim of the study was to determine the prevalence of potential drug-drug interactions (DDIs) between hydroxychloroquine, lopinavir/ritonavi...

Full description

Saved in:
Bibliographic Details
Main Authors: Allan Ramos-Esquivel (Author), Cristina Fernández (Author), Luis Garro-Zamora (Author), Ana Victoria Chaves (Author), Álvaro Víquez-Jaikel (Author)
Format: Book
Published: Research Center for Rational Use of Drugs (RCRUD), 2022-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items